Call for Abstracts

The Online Submission System is now open.

On behalf of the Scientific Committee of the STI & HIV 2019 World Congress, Joint Meeting of the 23rd ISSTDR & 20th IUSTI Congress in Vancouver, Canada, we would like to thank you for your interest in submitting an abstract. Showcase your research to an international audience and contribute toward discussions that will shape future health policies and patient care around the world.Please click the button below to submit your abstract. 

All submissions must be made online by January 25, 2019 (23:59 PST).

Submit Abstract

We currently have abstract submissions from 35 countries!


Important Deadlines
  • Abstract Submission Deadline: January 25, 2019 (23:59 PST)
  • Scholarship Application Deadline: January 25, 2019 (23:59 PST)
  • Abstract Notifications: March 8, 2019
  • Abstract Scholarship Notifications: March 8, 2019
  • Late Breaking Abstract Submission Deadline: March 22, 2019 (23:59 PST)
  • Presenting Author Registration Deadline: April 5, 2019 (23:59 PST)
  • Late Breaking Abstract Notifications: April 5, 2019
  • Early Registration Deadline: April 5, 2019
Abstract Submission Guidelines
  • All submissions must be made online by January 25, 2019 (23:59 PST).
  • If an abstract is accepted for presentation, the presenting author must attend the Congress to present the abstract. The presenting author will be required to register for the Congress by April 5, 2019 in order to have the abstract acceptance confirmed. If a presenting author is not registered by April 5, 2019, the Scientific Committee will remove the abstract from the program.
  • All abstracts will be reviewed, scored and accepted or rejected by the Scientific Committee. The Committee reserves the right to determine whether an abstract submission is accepted as an oral presentation or poster. The decision of the Committee is final.

General Guidelines
  • Abstracts should contain new information and not have been presented before.
  • We strongly discourage submission of abstracts that contain incomplete data and/or analysis.
  • All abstracts must be submitted in ENGLISH.
  • Specify all abbreviations in full at the first mention, followed by the abbreviation in parentheses. Use the abbreviation thereafter.
  • Check abstract thoroughly for spelling and grammar.
  • Do not include references.
  • Abstract presenters who are not scholarship recipients will be required to fund in full their own attendance at the Congress (including Congress registration and travel expenses) and should not accept to present an abstract if this is not possible.
  • All accepted and presented abstracts will be published in an international journal prior to the Congress.
  • Please indicate at the time of abstract submission if you wish to apply for a scholarship. Please see the scholarship information page for further details.

All Abstracts MUST include:

  • TITLE:
    • Maximum 125 characters
    • Basic Science & Translational Research
    • Clinical Science
    • Epidemiology & Monitoring
    • Policy & Community Engagement
    • Behavioral & Social Science
    • Program & Implementation Science
    • Full name, email address and affiliation(s) are mandatory for each author.
    • Indicate the presenting author for the abstract.
    • Maximum 300 words (authors and title not included)
    • Abstract must be structured as follows:
      • Background: study objectives, hypothesis tested, or description of problem.
      • Methods: method used, or approach taken.
      • Results: present in summarized form, must include data and/or substantial information about results, but do not include tables, graphs or pictures.
      • Conclusion: description of main outcomes of the study. Include knowledge or insight that Congress attendees will gain from the presentation, and an explanation of how Congress attendees can apply the skills and/or knowledge within their communities.
Disclosure of Interest

ISSTDR and IUSTI recognize the considerable contribution that industry partners make for professional and research activities. We also recognize the need for transparency and the disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.

The abstract submitter and presenting author will each need to provide disclosure information. This statement will not count towards the 300 word limit. If your abstract is accepted, you will be requested to include a Disclosure of Interest statement in your oral or poster presentation. 

By submitting an abstract, all authors agree to release the license to the Congress organizers and give permission to publish the abstract in the Congress handbook and on the website (and by doing so, certify that the abstract is original work).

Congress Newsletter


Subscribe to the Newsletter to receive important information about the upcoming congress.